We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Device Products » Real World Evidence and the NEST Program: An FDA Perspective - Webinar Recording/Transcript

Other Options

Audio Recording/Transcript - July 17, 2018

$287.00

Audio Recording/Transcript - July 17, 2018

$258.00

Audio Recording/Transcript - July 17, 2018

$244.00

Audio Recording/Transcript - July 17, 2018

$230.00

Audio Recording/Transcript - July 17, 2018

$215.00

Real World Evidence and the NEST Program: An FDA Perspective - Webinar Recording/Transcript

$287.00
Device Products

Product Details

Real World Evidence and the NEST Program: An FDA Perspective — Evaluating Benefit & Risk: What Devicemakers Need to Know

The FDA is working with stakeholders across the medical device community to simplify the evaluation of new medical devices via Real World Evidence (RWE). A key component of that effort is the National Evaluation System for Health Technology, or NEST … and it could benefit you.

One of the agency’s RWE leaders gives you a view into FDA’s thinking and activities related to the use of RWE and the exciting potential for NEST.

Owen Faris, Ph.D. is Director of the Clinical Trials Program at CDRH, FDA. Over the course of a fast-paced 90 minutes, he’ll bring you up to speed on how FDA views the current and potential uses of RWE for medical devices and what NEST may be able to do for you:

  • Real World Evidence (RWE): Why the FDA is promoting it to evaluate medical devices
  • How to support the NEST effort
  • Proof of concept as it applies to using RWE for device evaluation
  • Best practices and success stories
  • Your specific medical devices: How RWE and NEST can specifically apply to their development
  • And much more!

NEST is seen as a real opportunity to find “better, faster, cheaper” approaches to evidence-based generation for device evaluation … and get your new products to market and to patients in less time.

  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing